Reference

Safety & sourcing

The parts nobody selling you peptides has an incentive to explain.

“Not for human consumption” is a legal position, not a finding

Almost every peptide sold online carries a research-use-only label. It is easy to read that as a formality - a wink, a liability shield. It is a liability shield. It is also an accurate description of what the seller has and has not done.

A pharmaceutical product carries guarantees: this vial contains this molecule, at this purity, at this quantity, sterile, manufactured under inspected conditions, with a stability study behind its expiry date. Research-grade material carries none of those by default. Not because it is necessarily bad, but because nothing in the chain required anyone to verify it.

The FDA has issued warning letters to peptide sellers over exactly this - marketing unapproved drugs to consumers while labelling them research chemicals. The label does not change what the product is; it changes who is liable when it goes wrong.

What a certificate of analysis does and does not tell you

A COA is the main quality signal available in this market, and it is routinely misunderstood. A typical peptide COA reports:

  • Identity - usually by mass spectrometry. Confirms the molecular weight matches the intended peptide. Good evidence you have roughly the right molecule.
  • Purity - usually by HPLC, reported as a percentage. This is peak area, meaning “98% pure” describes the proportion of detected material that is the target peptide. It says nothing about what the other 2% is.
  • Net peptide content - frequently absent, and the most commonly missing number that matters. Lyophilised powder includes counter-ions and residual water. A vial can be 99% pure and still contain meaningfully less peptide than the label claims.

What a standard COA generally does not cover:

  • Sterility and endotoxin. This is the one that puts people in hospital. Purity testing does not detect bacterial endotoxin, and endotoxin survives sterile filtration. It is a separate assay, and it is rarely run.
  • Heavy metals and residual solvents from synthesis.
  • That this document belongs to this batch. Recycled and stale COAs are common. A COA with no batch number matching your vial establishes nothing at all.

How to actually evaluate a supplier

  • Third-party, batch-specific testing - an independent lab, a batch number on the report that matches the vial, and a date. Vendor-run internal testing is a different claim.
  • Evidence they have failed a batch and said so. This is the strongest signal available. Every real testing programme produces failures; a vendor with a hundred-percent pass rate is either lucky, small, or not publishing everything. A supplier who tells you a batch failed and is out of stock is behaving correctly.
  • Community-funded independent testing. Several peptide communities pool money to send vials to independent labs. This is generally more reliable than anything a vendor publishes, because nobody paying for it is selling the result.
  • Consistency over time, not one impressive report.

The failure modes that actually hurt people

Ranked roughly by how often they cause real harm, which is not the order most people worry about them:

  1. Dosing errors. Misreading units for millilitres, or mg for mcg. An order of magnitude is one decimal point. This is the most common serious incident by a wide margin, and it is entirely preventable - which is why the calculator exists.
  2. Contamination and non-sterile technique. Injection-site abscesses and cellulitis. Reusing needles, touching the injection site after cleaning, not swabbing the vial stopper.
  3. Endotoxin in the product. Fever, chills and malaise a few hours after injecting. Frequently mistaken for a side effect of the peptide.
  4. Underlying conditions nobody looked for. Treating symptoms of an undiagnosed problem, and delaying the diagnosis in the process.
  5. Interactions with prescribed medication. Which your doctor cannot warn you about if you have not told them.

Tell your doctor

The most common reason people do not is expecting judgement. A clinician cannot help you with an interaction, an abnormal lab, or a symptom they do not know the cause of - and anyone competent is more interested in keeping you safe than in disapproving. If your doctor is not that person, find one who is, but do not solve it by withholding information.

If you are using anything on this site, get baseline bloodwork first and repeat it. For incretins: metabolic panel, HbA1c, lipids. For anything touching the GH axis: IGF-1 and fasting glucose. For anything hormonal: a full male hormone panel including LH and FSH. Without a baseline you cannot tell a change from a coincidence.

Where people talk about this

Community discussion is genuinely useful for practical logistics and vendor reputation, and genuinely unreliable for anything pharmacological. Sizes below were verified against public listings.

CommunityMembersFocus
r/Biohackers884KBroad self-experimentation; peptides are one thread among many
r/Semaglutide201KFDA-approved semaglutide only - compounded discussion is removed
r/Mounjaro200KPrescription tirzepatide: Mounjaro and Zepbound experiences
r/tirzepatidecompound186KThe largest tirzepatide community, compounded and grey-market included
r/Peptidesource104KLong-running peptide research and sourcing discussion
r/PeptideForum52KGeneral peptide education and experience reports
r/GLP138KAll GLP-1 agonists, cross-brand

Read them with the selection bias in mind. People post when something dramatic happens. The large silent majority for whom nothing much happened does not generate threads, so forums systematically overstate both benefit and harm.